Furosemide-Claris 20mg/2ml Injection – AUST R 148003, intended for the Australian market (CLDA (16)A/04)
- The problem
- Claris Lifesciences UK Ltd are asking pharmacists and wholesalers to check packs of Furosemide-Claris 20mg/2ml Injection (Marketing Authorisation number AUST R 148003) as they have been inadvertently distributed in the UK and are intended for the Australian market.
- What to do
- Check the batch number on your pack against the list below. Do not stop taking a prescribed medicine without talking to your pharmacist, GP or prescriber first – they can check your supply and swap it if needed.
Product information
CLDA number
CLDA (16)A/04
MDR number
MDR 11-08/16
Company name
Claris Lifesciences UK Ltd
Product description
Furosemide-Claris 20mg/2ml Injection Marketing Authorisation number AUST R 148003, intended for the Australian market.
Batch number/expiry
| Batch no | Expiry date |
|---|---|
| B550131 | April 2018 |
Brief description of the problem
Claris Lifesciences UK Ltd has informed us that, due to the possible mislabelling of shipping cartons at the manufacturing site, some packs of the above product may have inadvertently been distributed in the UK. Pharmacists and wholesalers are asked to check their stock of this product and notify Claris Lifesciences UK Ltd if any Australian packs from the above batch are identified.
Company contact for all enquiries
Claris Lifesciences UK Ltd
The Granary, The Courtyard Barns
Choke Lane, Cookham Dean,
Maidenhead, Berkshire
SL6 6PT
United Kingdom
Tel: 01908 363498
Email: medinfo@peckforton.com
Updated 10 August 2016. This page summarises an official notice. Details can change – always follow the official notice.